CoreAge Rx vs Ivy Rx
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Ivy Rx head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 74 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Ivy Rx a bad call — it's best for readers willing to confirm the medication, complete payment and renewal terms before choosing a glp-1 subscription. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Ivy Rx |
|---|---|---|
| Brief Score | 94/100 (A) | 74/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm current price Shared GLP-1 offer starts at $77; medication-specific total, prepaid term and renewal need confirmation. Full price detailsCompounded semaglutide offered; current medication quote unknown; earlier listing: From $175/mo (starting dose, compounded) |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm current price Shared GLP-1 offer starts at $77; medication-specific total, prepaid term and renewal need confirmation. Full price detailsCompounded tirzepatide offered; current medication quote unknown; earlier listing: From $275/mo (starting dose, compounded) |
| Coverage | US only; restrictions by state, confirmed at intake | Confirm medication-specific access for your location; reviewed public pages do not establish a current state roster |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Ivy Rx: The current $77 floor covers a shared GLP-1 listing, without a separate complete semaglutide or tirzepatide quote. Earlier molecule prices remain historical.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.